|
WO2019212427A2
|
|
Compositions comprising erdosteine and ascorbic acid
|
|
WO2020022974A2
|
|
A pharmaceutical composition comprising prucalopride and a proton pump inhibitor
|
|
WO2019212426A2
|
|
Delayed release dexketoprofen composition
|
|
TR201820835A1
|
|
A Formulation Containing Dexrabeprazole.
|
|
WO2019216837A1
|
|
Novel pharmaceutical compositions
|
|
WO2020022975A2
|
|
New pharmaceutical compositions in the treatment of copd
|
|
TR201400835A2
|
|
Formulations comprising third generation cephalosporin
|
|
TR201205320A2
|
|
Galantamine formulations and production method
|
|
TR201204300A2
|
|
Method for preparation of tablet formulations comprising esomeprazole.
|
|
TR201203404A2
|
|
A combination comprising alpha lipoic acid and vitamin b.
|
